Skip to Main Content

Author Details

Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
2000
98
37
PMIDPaper TitleJournal TitlePublished Year
37291228B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.Nat Commun2023
35170269Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection.Clin Chem Lab Med2022
35475723Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.Clin Chem Lab Med2022
35568821Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line.Clin Proteomics2022
35512584Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms.Biosens Bioelectron2022
36179121Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay.J Appl Lab Med2022
36380677Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.Clin Chem Lab Med2022
35883559Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.Biomolecules2022
36287134Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.Clin Chem Lab Med2022
34868557Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.F1000Res2021
33778875Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.J Appl Lab Med2021
32315192Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid.J Proteome Res2020
31904348Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.Clin Biochem2020
33299547Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry.F1000Res2020
31249498A proteome-wide immuno-mass spectrometric identification of serum autoantibodies.Clin Proteomics2019
32047603Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury.F1000Res2019
31415236Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.Clin Chem Lab Med2019
31467673Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.Transl Neurodegener2019
31346327Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies.Clin Proteomics2019
31363009Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive Value.Mol Cancer Ther2019
28586166Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers.Arthritis Care Res (Hoboken)2018
29958881Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.Clin Biochem2018
29768245Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.Clin Chem Lab Med2018
29378650Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.Alzheimers Res Ther2018
28636767Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.Mol Oncol2017
28330469Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility.BMC Med2017
28427756Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.Radiother Oncol2017
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28343172Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases.Clin Chem Lab Med2017
28115917A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9.Clin Proteomics2017
28672746Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids.Clin Chem Lab Med2017
28746862Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids.Clin Biochem2017
27371727Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.Mol Cell Proteomics2016
27168011An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.J Proteomics2016
25519722An enzyme-linked immuno-mass spectrometric assay with the substrate adenosine monophosphate.Anal Bioanal Chem2015
25813379Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids.Mol Cell Proteomics2015
25436002OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.Oncol Lett2015
25153388Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.Biol Chem2014
23096109Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease.Clin Chem Lab Med2013
24259048Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma.Sci Transl Med2013
24007603Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.BMC Cancer2013
23136250Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.Clin Chem2013
22681384Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.J Proteome Res2012
22985796CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer.Clin Biochem2012
22539431Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry.Proteomics2012
20924077Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.Ann Oncol2011
19883638Nidogen-2: a new serum biomarker for ovarian cancer.Clin Biochem2010
20180649Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.Biol Chem2010
20180642Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.Biol Chem2010
18945921Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.Diabetes Care2009
  • 1 - 50 of 98

Recommended Authors

Seong Beom Ahn
Macquarie Medical School, Macquarie University
Career Start Year 2011
Number of shared co-authors 0
Elisa Pin
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 0
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 1
Athena A Schepmoes
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 0
Bryan Krastins
Nuclea Biotechnologies
Career Start Year 2005
Number of shared co-authors 2
Hyoung-Joo Lee
Yonsei University
Career Start Year 2005
Number of shared co-authors 0
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 0
Sharon J Pitteri
Stanford University
Career Start Year 2003
Number of shared co-authors 0
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 0
Stella Somiari
Windber Research Institute
Career Start Year 2000
Number of shared co-authors 0
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 0
David W Powell
University of Louisville School of Medicine
Career Start Year 1998
Number of shared co-authors 0
??kos V??gv??ri
Karolinska Institutet
Career Start Year 1998
Number of shared co-authors 0
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 2
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 12
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 1
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 2
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 1
Ruo-Pan Huang
Raybiotech Co.
Career Start Year 1988
Number of shared co-authors 0
Lori J Sokoll
Division of Clinical Chemistry, Johns Hopkins University
Career Start Year 1988
Number of shared co-authors 2
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 5
Fred C G J Sweep
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 4
Stephen R Pennington
UCD Conway Institute, University College Dublin
Career Start Year 1985
Number of shared co-authors 1
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 1984
Number of shared co-authors 0
Mark S Baker
Macquarie University
Career Start Year 1984
Number of shared co-authors 0
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Career Start Year 1979
Number of shared co-authors 2
Ludwig Wagner
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Samir M Hanash
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 1
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 96
Ioannis Prassas
Mount Sinai Hospital
Co-authored papers 15
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 3
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Manik C Ghosh
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Tony Mazzulli
Mount Sinai Health System and University Health Network
Co-authored papers 1
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 1
Sevtap Savas
Memorial University
Co-authored papers 1
David Z I Cherney
University Health Network, University of Toronto
Co-authored papers 1
Salvador Mejia-Guerrero
Princess Margaret Cancer Center, University Health Network
Co-authored papers 1
Jingxiong Xu
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
Vesta Lai
Toronto General Hospital (Y.L.
Co-authored papers 1
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Tristan Juvet
Lions Gate Hospital
Co-authored papers 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Zhen Zhang
Co-authored papers 1
Heather N Reich
University Health Network and University of Toronto
Co-authored papers 1
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 1
Jeremy A Squire
University of Sao Paulo
Co-authored papers 1
Karen Chadwick
University Health Network, University of Toronto
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Judith A Miller
University of Toronto
Co-authored papers 1
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 1
Neil E Fleshner
University of Toronto
Co-authored papers 1
Release 1.2